Bioxytran, Inc
BIXT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001445815
No open-market purchases or sales by Bioxytran, Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Bioxytran, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Bioxytran, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hoberman Alan M | Director | 210,000 | Nov 18, 2025 | 1 |
| Milanova Radka | Director | 203,688 | Nov 18, 2025 | 1 |
| Conaway Dale H | Director | 379,177 | Nov 18, 2025 | 1 |
| Utter Anders | Director | 372,580 | Nov 18, 2025 | 1 |
| Platt David | CEO | 20,038,903 | Nov 18, 2025 | 1 |
| Soderquist Ola | CFO | 500,000 | Nov 18, 2025 | 1 |
| Sheikh Michael | CCO | 8,214,720 | Nov 18, 2025 | 1 |
| Chen-Walden Hana | Director | 367,800 | Oct 10, 2023 | 0 |
| Offer Binder | Other: No longer 10% owner | – | Jul 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 (view filing)4:15 PM ET | Nov 18 | Same day | Hoberman Alan MDirector | PPurchasecommon | +210.0K | $0.60 | +$126.0K | New position210.0K after | |
| Aug 20, 2024 (view filing)5:10 PM ET | Aug 15 | 5 daysLate | Platt DavidCEO | PPurchasecommon | +1.59M | $0.124 | +$197.5K | +7.9%21.7M after |